Can board games sharpen minds in schizophrenia?

NCT ID NCT07781007

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial tests whether a weekly board game session, held over 12 weeks, can improve thinking and daily living skills in older adults with schizophrenia who live in psychiatric nursing homes. Participants are randomly assigned by group to either the board game program or usual care. Researchers will compare cognitive and functional abilities before, right after, and three months following the program to see if the games make a lasting difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Scaffolding-based board game intervention
What this could lead to
If effective, this low-cost, engaging activity could offer a practical way to support cognitive and daily living skills in older adults with schizophrenia living in care facilities.
What could go wrong
This is a relatively small trial, and results may not apply broadly. The benefits, if any, might be modest or not lasting beyond the intervention period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 55 years or older. 2. Diagnosed with schizophrenia by a board-certified psychiatrist. 3. Has completed at least elementary school education. 4. Has basic verbal communication ability and is able to understand and cooperate with study assessments and activities. 5. Has sufficient vision and hearing, as assessed by care staff, to participate in board game instructions and activities. 6. Is willing to participate in the study and provides written informed consent. Exclusion Criteria: 1. Has severe sensory impairment. 2. Has severe visual or hearing impairment that interferes with participation in the study activities. 3. Has experienced an acute exacerbation of psychiatric symptoms within the past 3 months. 4. Is currently receiving other cognitive training or participating in another research study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schizophrenia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Daliao Psychiatric Nursing Home, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital

    Kaohsiung City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.